A. Salihoglu Et Al. , "Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey," ANNALS OF HEMATOLOGY , vol.94, no.3, pp.415-420, 2015
Salihoglu, A. Et Al. 2015. Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey. ANNALS OF HEMATOLOGY , vol.94, no.3 , 415-420.
Salihoglu, A., Elverdi, T., KARADOGAN, I., PAYDAŞ, S., ÖZDEMİR, E. R., ERDEM, G., ... KARADURMUS, N.(2015). Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey. ANNALS OF HEMATOLOGY , vol.94, no.3, 415-420.
Salihoglu, A. Et Al. "Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey," ANNALS OF HEMATOLOGY , vol.94, no.3, 415-420, 2015
Salihoglu, A. Et Al. "Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey." ANNALS OF HEMATOLOGY , vol.94, no.3, pp.415-420, 2015
Salihoglu, A. Et Al. (2015) . "Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey." ANNALS OF HEMATOLOGY , vol.94, no.3, pp.415-420.
@article{article, author={A. Salihoglu Et Al. }, title={Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey}, journal={ANNALS OF HEMATOLOGY}, year=2015, pages={415-420} }